Save €40 now
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Mon, 17 Jul, 2023
Leading US generic drugmaker Perrigo has formally completed its $8.6bn (€6.5bn) takeover of Irish biotech firm Elan in a cash and share deal.
Fri, 20 Dec, 2013
US pharmaceutical Perrigo will benefit from around $150m (€113m) in annual tax savings from acquiring Elan, its chief executive said yesterday.
Tue, 30 Jul, 2013
News
Monday, November 9, 2026 - 4:00 PM
Monday, November 9, 2026 - 10:00 AM
Friday, November 6, 2026 - 3:00 PM